The Smoking Impact Assessment Profile is a health screening package that includes 31 laboratory parameters to evaluate blood health, long-term blood sugar levels, selected liver-related markers, inflammation, and Vitamin D status.
The package includes a Complete Blood Count (CBC), HbA1c, estimated average blood glucose, GGTP (Gamma GT), Vitamin D, and ESR, providing information about selected health markers that may be affected by smoking or associated lifestyle factors.
It may help healthcare professionals identify certain blood-related, metabolic, and inflammatory abnormalities in individuals who smoke or have a history of tobacco use.
Important: This package does not directly measure smoking exposure, lung function, or smoking-related lung damage. Normal results do not rule out smoking-related diseases.
Fasting
Not required
Report time
Within 72-96 hours
Recommended for
Male & Female
Age group
18–99 years
Tests
5 tests
Parameters
31 parameters
Parameters measured (26)
The Smoking Impact Assessment Profile is a laboratory screening package designed to evaluate selected blood, metabolic, nutritional, and inflammatory markers in adults who smoke or have previously smoked.
Also known as: Smoking Health Checkup Package, Smoker's Blood Test Profile, Tobacco Use Health Assessment, Smoking-Related Health Screening Package, Smoking Impact Blood Test.
Smoking tobacco exposes the body to nicotine, carbon monoxide, and numerous other chemicals that can affect the respiratory system, cardiovascular system, blood vessels, and other organs.
Long-term smoking is associated with increased risks of cardiovascular disease, chronic obstructive pulmonary disease (COPD), several cancers, and other health conditions.
Smoking can also influence certain laboratory measurements, including hemoglobin, hematocrit, and white blood cell counts.
This package evaluates:
These investigations may help healthcare professionals identify selected abnormalities requiring further evaluation.
However, smoking-related health risks cannot be accurately determined using these blood tests alone.
The Smoking Impact Assessment Profile may be suitable for:
Important: This package is not a substitute for smoking cessation support, lung function testing, or recommended lung cancer screening.
It is a laboratory screening package containing 31 parameters that evaluate blood cell counts, HbA1c, estimated average blood glucose, GGTP, Vitamin D, and ESR.
The package includes 31 parameters across 5 test groups.
No. Fasting is not required.
It may identify certain laboratory abnormalities, but it cannot directly measure or diagnose all smoking-related damage.
| Package name | Smoking Impact Assessment Profile |
|---|---|
| Location | Jammu |
| Sample type | Blood |
| Number of tests | 5 |
| Number of parameters | 31 |
| Home sample collection | Available |
| Fasting | Not required |
| Report time | Within 72-96 hours |
| Recommended age | 18–99 years |
| Suitable for | Male & Female |
Parameters measured (2)
# What Is Included in the Smoking Impact Assessment Profile?
# 1. Complete Blood Count (CBC)
The Complete Blood Count evaluates red blood cells, white blood cells, hemoglobin, and platelets.
Smoking may influence certain blood measurements, particularly in individuals exposed to carbon monoxide from tobacco smoke.
The package includes:
Some smokers may have elevated hemoglobin or hematocrit levels, potentially related to chronic exposure to carbon monoxide or reduced oxygen availability.
Smoking may also be associated with changes in white blood cell counts.
However, these findings are nonspecific and cannot independently establish smoking-related disease.
# 2. Glycated Hemoglobin (HbA1c)
HbA1c measures the proportion of hemoglobin with glucose attached to it.
It reflects average blood glucose levels over approximately two to three months.
Smoking is associated with an increased risk of developing type 2 diabetes.
HbA1c may help screen for diabetes or prediabetes and assess longer-term glucose control.
Abnormal HbA1c results should be interpreted according to established diagnostic criteria and clinical circumstances.
# 3. Average Blood Glucose
Estimated average blood glucose is generally calculated from HbA1c.
It provides an approximate representation of average blood sugar levels over the preceding two to three months.
This measurement may help individuals understand HbA1c results in familiar glucose units.
It is not a separate direct measurement of fasting blood glucose.
# 4. GGTP (Gamma GT)
Gamma-glutamyl transferase, commonly called GGT or GGTP, is an enzyme found in the liver and other tissues.
Elevated GGT levels may occur in certain liver and biliary conditions.
Smoking, alcohol consumption, medications, and other factors may influence GGT levels.
However, GGT alone cannot determine whether smoking has caused liver damage.
# 5. Vitamin D Total-25 Hydroxy
Vitamin D supports bone health, calcium absorption, and normal muscle function.
The Vitamin D Total-25 Hydroxy test measures the main circulating form of Vitamin D used to assess Vitamin D status.
Low Vitamin D levels may occur for several reasons, including inadequate intake, limited sunlight exposure, and certain medical conditions.
Vitamin D testing does not measure smoking-related damage.
# 6. ESR (Erythrocyte Sedimentation Rate)
ESR is a nonspecific laboratory marker associated with inflammation.
Elevated ESR may occur in infections, inflammatory conditions, and other medical situations.
Although smoking can contribute to chronic inflammatory processes, ESR cannot specifically identify smoking-related inflammation or diagnose lung disease.
# Why Is the Smoking Impact Assessment Profile Done?
Healthcare professionals may recommend selected investigations from this package to:
The package may be considered as part of a broader medical assessment for adults with current or previous tobacco exposure.
Note: Evaluation of smoking-related lung disease may require spirometry, imaging, or other investigations based on symptoms and clinical risk factors.
# Benefits of the Smoking Impact Assessment Profile
# Preparation Before the Test
The Smoking Impact Assessment Profile requires a blood sample.
Do not stop prescribed medicines without medical advice.
# Healthy Tips for Reducing Smoking-Related Health Risks
Yes. It includes 26 CBC parameters.
Yes. Some smokers may have elevated hemoglobin or hematocrit, particularly with chronic carbon monoxide exposure. However, other medical conditions can also cause these changes.
Yes. Glycated Hemoglobin (HbA1c) is included.
Yes. Smoking is associated with an increased risk of developing type 2 diabetes.
No. The supplied parameter list includes HbA1c and estimated average blood glucose, but not a separate fasting glucose test.
It includes GGTP (Gamma GT), which is a liver-related enzyme. A complete liver function panel is not included.
Yes. Vitamin D Total-25 Hydroxy is included.
Yes. ESR (Erythrocyte Sedimentation Rate) is included.
No. The included blood tests cannot diagnose or reliably screen for lung cancer.
No. Spirometry or other pulmonary function tests are not included.
No. COPD diagnosis generally requires clinical assessment and spirometry demonstrating persistent airflow obstruction.
No. Nicotine or cotinine testing is not included.
No. Carboxyhemoglobin or breath carbon monoxide testing is not included.
No. Smoking-related damage may occur even when routine laboratory results are within normal ranges.
It may be useful when a healthcare professional recommends these investigations, but testing should be based on individual health risks and symptoms.
Some adults with substantial smoking histories may benefit from low-dose CT screening depending on age, smoking exposure, and applicable clinical guidelines. A healthcare professional can assess eligibility.
Yes. Quitting smoking reduces the risk of cardiovascular disease, respiratory disease, cancer, and several other smoking-related conditions.
Home blood sample collection may be available through OnHealth in supported locations, subject to partner laboratory availability.
Reports are generally available within 72–96 hours, subject to confirmation by the partner laboratory.
Testing frequency depends on medical history, symptoms, existing conditions, and previous results. Routine repetition of the entire package is not necessary for every smoker.